@DNA vaccine is a novel immunization technology using molecular biology
technique. It delivers antigen(s) into body as genes encoding antigen
proteins. From these genes, antigen protein(s) is expressed and works to
elicit specific immune responses. Because DNA vaccine is expected to show
high performance to treat diseases such as cancers and virus infections and
the manufacturing of DNA-based drugs is relatively easy, it is considered to
be a next generation vaccine following to protein vaccines. We are intending
to develop gmultifunctional DNA vaccinesh that can totally activate the
antigen-specific immune responses by expressing various immunological
stimulatory molecules as well as antigen proteins. We have already
established relating patents and are now conducting basic and drug discovery
research program in close relationship with Mie University, our research
partner in Japan, in order to accelerate the translation of this new vaccine
technology from the bench to the clinic.